These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 3127597)

  • 21. Experimental studies on cholera immunization. 4. The antibody response to formalinized Vibrio cholerae and purified endotoxin with special reference to protective capacity.
    Svennerholm AM
    Int Arch Allergy Appl Immunol; 1975; 49(4):434-52. PubMed ID: 808500
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spleen autotransplantation provides restoration of functional splenic lymphoid compartments and improves the humoral immune response to pneumococcal polysaccharide vaccine.
    Leemans R; Harms G; Rijkers GT; Timens W
    Clin Exp Immunol; 1999 Sep; 117(3):596-604. PubMed ID: 10469068
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral immunization of piglets with recombinant F4 fimbrial adhesin FaeG monomers induces a mucosal and systemic F4-specific immune response.
    Verdonck F; Cox E; Van der Stede Y; Goddeeris BM
    Vaccine; 2004 Oct; 22(31-32):4291-9. PubMed ID: 15474721
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Opsonic activity of bovine serum and mammary secretion after Escherichia coli J5 vaccination.
    Hogan JS; Todhunter DA; Tomita GM; Smith KL; Schoenberger PS
    J Dairy Sci; 1992 Jan; 75(1):72-7. PubMed ID: 1541744
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Construction of a non-toxigenic Escherichia coli oral vaccine strain expressing large amounts of CS6 and inducing strong intestinal and serum anti-CS6 antibody responses in mice.
    Tobias J; Svennerholm AM; Carlin NI; Lebens M; Holmgren J
    Vaccine; 2011 Nov; 29(48):8863-9. PubMed ID: 21983363
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Responses of antibody titers to intramammary immunization with Escherichia coli J5 bacterin.
    Hogan JS; Smith KL; Schoenberger P; Romig S; Thompson L
    J Dairy Sci; 1997 Oct; 80(10):2398-402. PubMed ID: 9361212
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The capacity and mechanism of bone marrow antibody formation by thymus-independent antigens.
    Koch G; Lok BD; van Oudenaren A; Benner R
    J Immunol; 1982 Apr; 128(4):1497-501. PubMed ID: 6174602
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibitory effect of lipopolysaccharide on immune response after DNA immunization is route dependent.
    Boyle JS; Brady JL; Koniaras C; Lew AM
    DNA Cell Biol; 1998 Apr; 17(4):343-8. PubMed ID: 9570151
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Age-related decline in the antibody response to E. coli lipopolysaccharide in New Zealand Black mice.
    Blankwater MJ; Levert LA; Hijmans W
    Immunology; 1975 May; 28(5):847-54. PubMed ID: 1093967
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Detection of specific antibodies in anti-Escherichia coli donor plasma and of its isolated immunoglobulins].
    Arkhipov NA; Golodnenkova VN; Krokhina MA; Temner RM; Moshiashvili IIa
    Probl Gematol Pereliv Krovi; 1981 Mar; 26(3):45-7. PubMed ID: 7015315
    [No Abstract]   [Full Text] [Related]  

  • 31. Combined vaccine regimen based on parenteral priming with a DNA vaccine and administration of an oral booster consisting of a recombinant Salmonella enterica serovar Typhimurium vaccine strain for immunization against infection with human-derived enterotoxigenic Escherichia coli strains.
    Lásaro MO; Luiz WB; Sbrogio-Almeida ME; Nishimura LS; Guth BE; Ferreira LC
    Infect Immun; 2004 Nov; 72(11):6480-91. PubMed ID: 15501779
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hapten-specific unresponsiveness in mice. IV.--Significance of anti-hapten antibody responses elicited by E. coli lipopolysaccharides in tolerant mice.
    Huchet R
    Ann Inst Pasteur Immunol (1985); 1986; 137C(3):273-81. PubMed ID: 3527030
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhanced interferon-gamma production and bacterial clearance in the liver of splenectomized mice in the models of Escherichia coli injection or intestinal obstruction.
    Ikuta S; Ono S; Kinoshita M; Seki S; Hiraide H; Mochizuki H
    Shock; 2004 May; 21(5):452-7. PubMed ID: 15087822
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Immunity of the skin--infection and percutaneous immunization of rabbits with E. coli ATCC 13676].
    Hammerschmidt W; Hellmann E
    Zentralbl Bakteriol Mikrobiol Hyg A; 1985 Apr; 259(2):252-67. PubMed ID: 3892981
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Affinity-purified Escherichia coli J5 lipopolysaccharide-specific IgG protects neutropenic rats against gram-negative bacterial sepsis.
    Bhattacharjee AK; Opal SM; Palardy JE; Drabick JJ; Collins H; Taylor R; Cotton A; Cross AS
    J Infect Dis; 1994 Sep; 170(3):622-9. PubMed ID: 8077720
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cross-reactivity of rabbit antibodies to lipopolysaccharides of Escherichia coli J5 and other gram-negative bacteria.
    Siber GR; Kania SA; Warren HS
    J Infect Dis; 1985 Nov; 152(5):954-64. PubMed ID: 2413146
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunization of cows with novel core glycolipid vaccine induces anti-endotoxin antibodies in bovine colostrum.
    Cross AS; Karreman HJ; Zhang L; Rosenberg Z; Opal SM; Lees A
    Vaccine; 2014 Oct; 32(46):6107-14. PubMed ID: 25242628
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of interleukin-10 depletion in vivo on the immune response to Porphyromonas gingivalis in a murine model.
    Herminajeng E; Sosroseno W; Bird PS; Seymour GJ
    J Periodontol; 2001 Nov; 72(11):1527-34. PubMed ID: 11759864
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Construction of non-toxic Escherichia coli and Vibrio cholerae strains expressing high and immunogenic levels of enterotoxigenic E. coli colonization factor I fimbriae.
    Tobias J; Lebens M; Bölin I; Wiklund G; Svennerholm AM
    Vaccine; 2008 Feb; 26(6):743-52. PubMed ID: 18191006
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antigenic crossreactivity and lipopolysaccharide neutralization properties of bovine immunoglobulin G.
    Tomita GM; Todhunter DA; Hogan JS; Smith KL
    J Dairy Sci; 1995 Dec; 78(12):2745-52. PubMed ID: 8675757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.